Bevy co-founders and working moms Carissa Janeway (left) and Lynda Attaway wanted to create a service for helping busy families keep things moving smoothly. Photo courtesy of Bevy

So much to do and so little time? We feel you. In a 2018 Pew Research Center survey, 60 percent of U.S. adults said they sometimes felt too busy to enjoy life. Bevy, an organization company serving greater Houston, is helping the overwhelmed and active do it all.

"Bevy was actually born from our-real life experiences," explains Lynda Attaway, co-founder and CEO of Bevy.

As the former co-founder and chief strategy officer of Sunnova Energy, she led a complex schedule until the demands of doing it all got to her. While climbing the corporate ladder for 18 years, she would "do whatever it took and stay as late as it took," to succeed.

While trying to raise her three children and balance a large role, she soon realized that many of her male colleagues had a stay-at-home wife who managed the at-home projects that can take so much time.

"I finally came to the realization that I could not be everything to everybody, which is a very common kind of syndrome that we tend to have as women," she shares. "Something needed to change."

The power of an extra set of hands

Attaway's former employee, now Bevy co-founder and COO, Carissa Janeway, had a seven-month-old and another child on the way when she made a plan to leave their energy company. That's when Attaway approached her with the idea of becoming her at-home project manager.

Janeway spent 15 to 20 hours a week helping Attaway with tasks like project managing a bathroom renovation, organizing the children's wardrobe, sending flowers to her mother-in-law, and making sure the nanny got paid. The two women realized how much people could benefit from having an extra set of hands, and Attaway quit her corporate job in 2017. Together, they co-founded Bevy in 2019, an organizational service for individuals and families that specializes in project management.

"It started from ourselves, and not being able to see something out there that was scalable and had that community, local touch that could really help women and families enjoy the time that they have," says Attaway.

Unlike a virtual assistant or personal assisting service, the women feel Bevy offers a more sophisticated approach.

"We're able to provide an elevated white-glove service, almost like a concierge service, where we can completely absorb the entire project and the managing aspects of it because of the level of experience that we have," says Janeway.

The team at Bevy prizes itself as your go-to home project manager. From decluttering your children's playroom to taking on simple errands that never leave your to-do list — Attaway and Janeway pride themselves on a full suite of services. The company's offerings include home organization, planning family events, project management, room renovation, and packing for a move.

While some projects can be completed remotely, Attaway stresses that they are very much a "local" company serving the greater Houston-area.

COVID-19 demands have disproportionately impacted women in the workplace, and more than 2.2 million women had dropped out of the workforce as of October. According to the Washington Post, the percentage of women working in the U.S. is the lowest it's been since 1988. When the school year began, 865,000 women dropped out of the labor force, compared with 216,000 men. With many schools maintaining virtual learning, the brunt of education is continuing to fall on mothers.

Things like contacting the plumber, setting up your at-home office, virtual schooling, and planning your child's Zoom-accessible birthday party can stack up quickly in a global pandemic.

"How are you able to have the mental capacity to do that? [Even] before the pandemic, this service was needed," emphasizes Janeway.

During the summer, Bevy worked with one family to compile a curriculum of summer fun to entertain active children at a time where summer camps were closed.

"We put together activity kits for the kids. We were able to get them through a whole month of activities that were very family-friendly," explains Janeway. The kits included daily activities like a neighborhood scavenger hunt, rock painting, and baking bread as a family. The parents didn't have to do the "legwork" of planning or buying the items, she shares.

Something for everyone

Maybe you're not a parent or a woman to use Bevy. Maybe you're a busy startup founder, a hard-working CFO, or a healthcare worker on the frontlines of the coronavirus pandemic.

"You don't have to have kids to have our service. You don't have to be married. Everybody needs a hand," Janeway explains.

Attaway, who is currently teaming up with several HR departments on ways to incorporate Bevy in benefit packages, says companies for years have supported employees with offer gym memberships and massages — why not give them time?

"Bevy is the gift of time... We're told to delegate at work. We're told that's how you get better and how you become managers, that you need to learn to delegate. Then, we're told to go home and do it all yourself," says Attaway. "This is a service where you can actually delegate at home, and on a broader base so that we can take on the complexity of it," she continues.

The team of project managers and assistants, called "Bevs," do home visits and phone consultations. Bevy features long-term subscriptions, where clientele would have a set number of hours to work with the Bevy team, as well as project-based options. Attaway and Janeway offer free consultations to assess the project needs and what the client is most looking for from their services.

When onboarding a new client, the Bevs call it a "deep dive," where they can do a virtual meeting or a socially-distanced, masked-on meeting. The team does "a lot of listening" before making a full list of things that need to happen for the client based on what they hear.

"We just start pouring out all the things that need to be done... we pull more and will encourage them to explore other areas," explains Attaway. As they tour client homes, they might point to areas where they feel the client may need some extra help. "We help them pull all the things that are kind of lying on their shoulders, and you start watching them kind of lift up," she says, regarding clients' demeanor.

The business of giving time

Trust is at the core of Bevy's client relationships, as the co-founders work out the best plan for each project.

"We're here to take care of you, [and] to help you. You deserve to have this taken care of for you," says Janeway. "We make sure they know that they're not alone — and they've felt so alone. Society has put so many expectations on our shoulders."

After the consultation, Bevy compiles a list of all the needs communicated and priorities to share with the client for their feedback. From there, they compose different package options for consideration. Clients can also set their own pace based on how quickly they need a project completed. At last, the Attaway and Janeway will assign a Bev from their team — or in some cases, themselves — to a client.

While the Bevs take on tasks like research and execution, they present clients with options for each project they take one. "Our goal is that our clients are in the decision-making seat," says Attaway.

When it comes to design and renovation, Janeway and Attaway both use their personal expertise to work on major home projects. Janeway, passionate about interior design, has loved providing her keen eye to a family's home to find solutions for making a room aesthetically-pleasing and purposeful. Attaway grew up in a hands-on family and has grown a savvy knowledge of construction.

One satisfaction of the job is watching clients' stress melt away. During a recent home visit, Attaway was faced with an overwhelmed client. As she broke down what tasks Bevy would take off her shoulders, the customer said she felt so much better being able to relay the tasks to her team. The stress was "falling off of her," she says, "that's why we do this."

"We do this because it changes people's lives," says Janeway, emphatically, as she recalls some of her favorite Bevy projects.

Packages at four hours of service at $360, but Bevy offers various discounts for the subscription service and larger package offerings.

The company that once ran on word-of-mouth is now venturing into Facebook advertisements and other forms of traditional marketing as they continue to build its customer base. In the future, Attaway and Janeway plan to create a digital platform and scale Bevy to cities across the country.

"We have a mission to help society and blow open the doors of how families manage homes," says Janeway.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Top stories: Houston's most-read health tech news of 2024

year in review

Editor's note: As the year comes to a close, InnovationMap is looking back at the year's top stories in Houston innovation. In the health tech category on InnovationMap, top stories included startup funding raised, IPO plans, FDA clearance, and more. Be sure to click through to read the full story.

New report ranks Houston top market for life sciences

Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. Photo by Natalie Harms/InnovationMap

Thanks in large part to producing hundreds of college-trained professionals, Houston’s life sciences industry ranks among the top U.S. markets for talent in 2024.

In a report published by commercial real estate services company CBRE, Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. From 2017 to 2022, Houston notched a growth rate of 32.4 percent in this category.

In 2022, the University of Houston led the higher education pack in the region, graduating 746 people with a bachelor’s degree or above in biological or biomedical sciences, according to the report. Continue reading.

Houston innovator raises pre-seed funding for health care staffing platform

Ayoade Joy Ademuyewo founded Lokum last year to create a solution to better connecting medical specialists with health care facilities nationwide. Photo courtesy of Lokum

A Houston health care innovator is celebrating an oversubscribed round of pre-seed funding to improve on her startup's unique staffing platform.

Ayoade Joy Ademuyewo founded Lokum last year to create a solution to better connecting medical specialists with health care facilities nationwide. The new platform, which cuts out the middleman and lowers staffing costs, raised $700,000 in pre-seed funding that will go toward further development of the technology.

"Healthcare organizations spend $26 billion annually to support a crippling dependence on third-party agencies for connecting with clinical staff," Ademuyewo says in a news release. "Technological solutions that are pointed precisely to streamline and strengthen the relationships between highly specialized clinicians and their future employers are vital to alleviating this detrimental dependance, and central to our mission." Continue reading.

Houston regenerative medicine company to IPO, move toward more human trials

FibroBiologics will IPO this week. Photo via Getty Images

Want a piece of one of Houston’s most promising biotech companies? On January 31, FibroBiologics will begin the trading of its common stock on the Nasdaq stock exchange.

While most labs in the realm of regenerative medicine are focused on stem cells, FibroBiologics has bet on fibroblasts as the secret to treating myriad ailments. Fibroblasts, the most common type of cell in the body, are the primary cells that compose connective tissue.

Interested investors can find a prospectus to peruse before taking the leap. FibroBiologics filed with the U.S. Securities & Exchange Commission (SEC) on November 7, 2023. In September, FibroBiologics CEO Pete O’Heeron told InnovationMap, “I think what we're going to see is that fibroblasts are going to end up winning... They're just a better overall cell than the stem cells.” Continue reading.

Houston organizations identify promising life science cos. at annual event

The Rice Alliance and BioHouston acknowledged innovations from a dozen promising health tech companies. Photo via Rice University

For the 13th year, the Texas Life Science Forum hosted by BioHouston and the Rice Alliance for Technology and Entrepreneurship celebrated innovative companies from around the world that are creating new treatments and solutions to today's biggest health care challenges.

This week, over 40 companies presenting their innovations across cancer, cardiovascular disease, biotechnology, and more. Nearly 700 venture capitalists, corporate innovation groups, angel networks, industry leaders, academics, service providers, and others attended the event on November 7 at Rice's BioScience Research Collaborative in the Texas Medical Center.

Just like in previous years, the event ended with the announcement of the 10 companies that were deemed "most promising" based on their pitches and technologies. Of the 10 companies named, six are headquartered in Houston and an additional two startups on the list have a presence here. Continue reading.

FDA greenlights Houston surgery robotics company's unique technology

EndoQuest Robotics secured an Investigational Device Exemption from the FDA for its clinical study. Photo via Getty Images

A Houston surgical robotics company has gotten a Investigational Device Exemption from the FDA to go forward with human trials.

This news allows EndoQuest Robotics to begin its Prospective Assessment of a Robotic-Assisted Device in Gastrointestinal Medicine (PARADIGM) study, which will be conducted at leading United States health care facilities, including Brigham and Women’s Hospital (Boston), Mayo Clinic (Scottsdale), Cleveland Clinic (Cleveland), AdventHealth (Orlando), and HCA Healthcare (Houston). The study will include surgeries on 50 subjects, who will hopefully begin to enroll in January.

“The foundational thesis is we're trying to make sure that the world's largest medical center is also the world's largest med tech innovation center,” Eduardo Fonseca, interim CEO of EndoQuest Robotics, tells InnovationMap. Continue reading.

Houston billionaire Tilman Fertitta nominated as ambassador to Italy

foreign affairs

Houston billionaire and Rockets owner Tilman Fertitta has been nominated to serve as the United States ambassador to Italy, according to U.S. President-elect Donald Trump.

On Saturday, Trump sent the following statement via Truth Social Post:

"I am pleased to announce that Tilman J. Fertitta has been nominated to serve as the United States Ambassador to Italy. Tilman is an accomplished businessman, who has founded and built one of our Country's premier entertainment and real estate companies, employing approximately 50,000 Americans. Tilman has a long history of giving back to the community through numerous philanthropic initiatives, which include children's charities, Law Enforcement, and the medical community. Additionally, Tilman is the longest serving Chairman of the Board of Regents for the University of Houston. He also owns the Houston Rockets Basketball Team. Congratulations to Tilman, and his remarkable family!"

Fertitta, 67, also is the chairman, CEO, and president of Landry's Inc. and the chairman of the University of Houston's board of regents.

"It is an honor to be nominated to serve my country as ambassador to Italy and I look forward to the process ahead. Italy is such an extraordinary country with its wonderful people, culture, and history and its strategic importance to The United States of America," Fertitta said.

---

Read the full story on CultureMap's news partner, ABC13.com.

Houston biotech biz to merge with public co., set local HQ

big deal

Houston-based Tvardi Therapeutics and Cara Therapeutics announced the companies have entered into a definitive merger agreement to combine in an all-stock transaction. Once completed, Houston will house the headquarters.

Tvardi is a clinical-stage biopharmaceutical company that focuses on the development of novel, oral, and small molecule therapies that target STAT3 to treat fibrosis-driven diseases. Tvardi will merge with a wholly owned subsidiary of Cara.

Once complete, the pre-merger Cara Therapeutics stockholders are expected to own approximately 17 percent of the combined company and pre-merger Tvardi Therapeutics investors are expected to own 83 percent of the combined company. Prior to adjustment from the issuance of the shares in the recently completed Tvardi financing and assuming Cara, which went public in 2014, has net cash at closing of between $22.9 million and $23.1 million with the percentage of the combined company that pre-merger Cara stockholders and pre-merger Tvardi stockholders will own upon the closing of the merger, which is subject to further adjustment if Cara’s net cash balance falls outside of the range.

“As we approach meaningful value inflection points next year, including two Phase 2 readouts of our lead program in idiopathic pulmonary fibrosis, followed by the readout in our hepatocellular carcinoma program, this merger, the recently completed financing, and becoming a publicly traded company give us access to the critical funding required to further advance our promising pipeline programs that address significant unmet needs,” Imran Alibhai, CEO of Tvardi Therapeutics, says in a news release.

Also, Tvardi has completed an approximately $28 million private financing from a syndicate of new and existing institutional investors. With the cash from both companies at closing and the proceeds of this financing, the post-merger company plans to have cash to fund its operating expenses and capital expenditure requirements into the second half of 2026.

“I am grateful to the Cara Board, leadership team, and shareholders who share our vision of Tvardi that is well-positioned to introduce effective, new treatment options to patients suffering from serious, chronic, fibrosis-driven diseases,” Alibhai continues.

In 2021, Tvardi emerged from stealth and closed a $74 million series B funding round led by New York-based Slate Path Capital, Florida-based Palkon Capital, Denver-based ArrowMark Partners, and New York-based 683 Capital, with continued support and participation by existing investors, including Houston-based Sporos Bioventures.